ATLANTA , July 25, 2024 /PRNewswire/ -- In a pivotal moment for improving the diagnosis and treatment of polycystic ovary syndrome (PCOS), an important PCOS Stakeholder Meeting is being held to address the urgent need for better diagnostic accuracy and health outcomes. This meeting, organized by PCOS Challenge: The National Polycystic Ovary Syndrome Association, in collaboration with and hosted by CDC Clinical Standardization Programs, aims to develop reference ranges for testosterone and other hormone tests in women and adolescent girls. Currently, inconsistent hormone level ranges across different tests and laboratories contribute to delays and errors in diagnosis, which can leave patients untreated for long periods of time.
By creating these reference ranges, this meeting aims to standardize and improve diagnostic precision and timeliness, ultimately supporting better health outcomes for those living with PCOS. Meeting Details The PCOS Stakeholder Meeting will be held on Monday, August 26, 2024 , from 9:00 AM to 3:30 PM EDT at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia . It will be a hybrid event, allowing participants to attend in person or virtually.
Sasha Ottey , Executive Director of PCOS Challenge, emphasizes, "The annual economic burden of PCOS exceeds $15 billion a year. As we continue to advocate for those affected by PCOS and to advance improved diagnostic and care models, this meeting marks a significant step forward. Establishing st.